The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
A Critical Appraisal of the Reporting of the National Acute Spinal Cord Injury Studies (II and III) of Methylprednisolone in Acute Spinal Cord Injury
Abstract
From the beginning, the reporting of the results of National Acute Spinal Cord Injury Studies (NASCIS) II and III has been incomplete, leaving clinicians in the spinal cord injury (SCI) community to use or avoid using methylprednisolone in acute SCI on the basis of faith rather than a publicly developed scientific consensus. NASCIS II was initially reported by National Institutes of Health announcements, National Institutes of Health facsimiles to emergency room physicians, and the news media. The subsequent report in the New England Journal of Medicine implied that there was a positive result in the primary efficacy analysis for the entire 487 patient sample. However, this analysis was in fact negative, and the positive result was found only in a secondary analysis of the subgroup of patients who received treatment within 8 hours. In addition, that subgroup apparently had only 62 patients taking methylprednisolone and 67 receiving placebo. The NASCIS II and III reports embody specific choices of statistical methods that have strongly shaped the reporting of results but have not been adequately challenged or or even explained. These studies show statistical artifacts that call their results into question. In NASCIS II, the placebo group treated before 8 hours did poorly, not only when compared with the methylprednisolone group treated before 8 hours but even when compared with the placebo group treated after 8 hours. Thus, the positive result may have been caused by a weakness in the control group rather than any strength of methylprednisolone. In NASCIS III, a randomization imbalance occurred that allocated a disproportionate number of patients with no motor deficit (and therefore no chance for recovery) to the lower dose control group. When this imbalance is controlled for, much of the superiority of the higher dose group seems to disappear. The NASCIS group's decision to admit persons with minor SCIs with minimal or no motor deficit not only enables statistical artifacts it complicates the interpretation of results from the population actually sampled. Perhaps one half of the NASCIS III sample may have had at most a minor deficit. Thus, we do not know whether the results of these studies reflect the severely injured population to which they have been applied. The numbers, tables, and figures in the published reports are scant and are inconsistently defined, making it impossible even for professional statisticians to duplicate the analyses, to guess the effect of changes in assumptions, or to supply the missing parts of the picture. Nonetheless, even 9 years after NASCIS II, the primary data have not been made public. The reporting of the NASCIS studies has fallen far short of the guidelines of the ICH/FDA and of the Evidence-based Medicine Group. Despite the lucrative "off label" markets for methylprednisolone in SCI, no Food and Drug Association indication has been obtained. There has been no public process of validation. These shortcomings have denied physicians the chance to use confidently a drug that many were enthusiastic about and has left them in an intolerably ambiguous position in their therapeutic choices, in their legal exposure, and in their ability to perform further research to help their patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bracken, M. B., Shepard, M. J., Collins, W. F., Holford, T. R., Young, W., Baskin, D. S., Eisenberg, H. M., Flamm, E., Leo-Summers, L., Maroon, J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005173222001 · Cited by 2,715
Bracken, M. B. (1997) · JAMA · doi:10.1001/jama.277.20.1597 · Cited by 1,397
Bracken, M. B. (1997) · JAMA · doi:10.1001/jama.1997.03540440031029 · Cited by 1,194
Bracken, M. B., Shepard, M. J., Collins, W. F., Holford, T. R., Baskin, D. S., Eisenberg, H. M., Flamm, E., Leo-Summers, L., Maroon, J. C., Marshall, L. F., et al. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.76.1.0023 · Cited by 725
Godlee, F., Gale, C. R., & Martyn, C. N. (1998) · JAMA · doi:10.1001/jama.280.3.237 · Cited by 333
The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats
Constantini, S., & Young, W. (1994) · Journal of Neurosurgery · doi:10.3171/jns.1994.80.1.0097 · Cited by 327
Bracken, M. B., & Holford, T. R. (1993) · Journal of Neurosurgery · doi:10.3171/jns.1993.79.4.0500 · Cited by 325
Steroids and Spinal Cord Injury: Revisiting the NASCIS 2 and NASCIS 3 Trials
Nesathurai, S. (1998) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199812000-00021 · Cited by 256
Consequences of High-Dose Steroid Therapy for Acute Spinal Cord Injury
Gerndt, S. J., Rodriguez, J. L., Pawlik, J. W., Taheri, P. A., Wahl, W. L., Micheals, A. J., & Papadopoulos, S. M. (1997) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199702000-00017 · Cited by 176
Cited by
Therapeutic interventions after spinal cord injury
Thuret, S., Moon, L. D. F., & Gage, F. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1955 · Cited by 1,012
Fitch, M. T., & Silver, J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.014 · Cited by 1,007
Donnelly, D. J., & Popovich, P. G. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.06.009 · Cited by 995
From basics to clinical: A comprehensive review on spinal cord injury
Silva, N. A., Sousa, N., Reis, R. L., & Salgado, A. J. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.002 · Cited by 814
Pathophysiology and pharmacologic treatment of acute spinal cord injury*1
KWON, B. (2004) · The Spine Journal · doi:10.1016/j.spinee.2003.07.007 · Cited by 696
Metadata
- Authors
- Coleman, W. P., Benzel, E., Cahill, D. W., Ducker, T., Geisler, F., Green, B., Gropper, M. R., Goffin, J., Madsen, P. W., Maiman, D. J., Ondra, S. L., Rosner, M., Sasso, R. C., Trost, G. R., & Zeidman, S.
- Venue
- Journal of Spinal Disorders
- Published
- 2000-06
- Volume
- 13
- Issue
- 3
- Pages
- 185-199
- ISSN
- 0895-0385 (ISSN-L)
- OpenAlex
- W2054934521
- Cited by
- 293
- References
- 13
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Critical Appraisal of the Reporting of the National Acute Spinal Cord Injury Studies (II and III) of Methylprednisolone in Acute Spinal Cord Injury. https://app.cochat.ai/papers/10.1097/00002517-200006000-00001
- The paper
- Coleman, W. P., Benzel, E., Cahill, D. W., Ducker, T., Geisler, F., Green, B., Gropper, M. R., Goffin, J., Madsen, P. W., Maiman, D. J., Ondra, S. L., Rosner, M., Sasso, R. C., Trost, G. R., & Zeidman, S. (2000). A Critical Appraisal of the Reporting of the National Acute Spinal Cord Injury Studies (II and III) of Methylprednisolone in Acute Spinal Cord Injury. Journal of Spinal Disorders. https://doi.org/10.1097/00002517-200006000-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.